Sysmex Corporation
Sysmex Corporation has acquired the shares of Hyphen BioMed SAS
DDA & Company represented the shareholders of Hyphen BioMed SAS, a scientific company boasting an extended experience in the field of Thrombosis, Haemostasis and Auto-Immunity providing a comprehensive offering of diagnostic and research reagents, distributed worldwide, on its sale to Japanese listed Sysmex Corporation
Hyphen BioMed SAS
DDA & Company
DDA & Company is an international corporate finance boutique with a presence in the US and Europe. We focus on a selection of advisory services including: * Mergers & Acquisitions * Strategic and Corporate Finance Advisory * Investment Management Outsourcing We have built a reputation as a first-rate M&A specialist targeting small and mid-cap companies, with a particularly strong expertise in structuring and negotiating cross-border deals. Our clients are entrepreneurs, investment funds or large international corporations, which we assist on the whole coporate finance value chain.
+1 212-472-6475
aodin@ddacompany.com
http://www.ddacompany.com/
